Oct 19, 2018 Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle ... Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle …For example, in the area of neurology no one has developed more FDA approved drugs over the past 10 years. “We are focused on developing ... read morePublished on 2018-10-19